Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised... by Oliveira, Mafalda, MD PhD, Rugo, Hope S, Prof, Howell, Sacha J, FRCP, Dalenc, Florence, MD PhD, Cortes, Javier, MD PhD, Gomez, Henry L, MD PhD, Hu, Xichun, Prof, Toi, Masakazu, MD, Jhaveri, Komal, MD FACP, Krivorotko, Petr, MD PhD, Loibl, Sibylle, Prof, Morales Murillo, Serafin, MD, Okera, Meena, MD, Nowecki, Zbigniew, MD, Park, Yeon Hee, Prof, Sohn, Joo Hyuk, MD, Tokunaga, Eriko, MD PhD, Yousef, Samih, MD, Zhukova, Lyudmila, MD PhD, Fulford, Marta, PhD, Andrews, Haylee, MPH, Wadsworth, Ian, PhD, D'Cruz, Celina, PhD, Turner, Nicholas C, Prof

Get full text